Urology Devices Market: Current Analysis and Forecast (2021-2027)
- UMHE21363
- Pages: 161
- August 2021
- Total Views:1130
- Region : Global
- UnivDatos Market Insights (UMI)
- Market Research Report

Details
Prevalence of various urological disorders has led to an upsurge in adoption of the urology devices globally. For instance, according to the American Urological Association Foundation (AUAF), benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections (UTIS), and kidney and ureteral stones are among the most common urological diseases. Moreover, as per the United States Department of Health and Human Services, the overall prevalence of CKD among the American population is about 14%, and almost half of the individuals with CKD suffer from diabetes and/or cardiovascular diseases. Annually, more than 661,000 Americans suffer from kidney failure, and 468,000 patients are given dialysis.
Urinary tract infections (UTIs) are one of the most common microbial diseases affecting people of all age groups. Globally, UTIs affect around 150 million people every year. Diabetic patients have a higher risk of developing UTIs and complications associated with it. With a global increase in diabetic population, complications, like dysuria and organ damage are associated with UTIs, that are also on the rise.
Based on product, the global Urology Devices market is segmented into instruments and consumables & accessories. Currently, instruments segment dominated the market and is expected to maintain its dominance during the forecast period owing to the technological advancements coupled with the launch of new and advanced urology instruments.
Based on diseases, the market is divided into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other diseases. Kidney diseases dominated the market in 2020 owing to the growing patient pool of chronic kidney disease due to the rising geriatric population.
Based on end-users, the market is segmented into hospitals and clinics, dialysis centers and others. Currently hospitals dominates the market and is expected to maintain its dominance during the analyzed period owing to the rising number of hospitals and infrastructural & economic development, especially in emerging countries.
For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for Urology Devices on account of increasing prevalence of chronic and lifestyle conditions, increasing healthcare spending, highly developed healthcare system in the US and Canada, and presence of a better reimbursement structure.
Some of the major players operating in the market includes Baxter, Boston Scientific, C. R. Bard, Medtronic, Siemens, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Becton, Dickinson and Company, Stryker Corporation, and Sanofi; etc.
Table Of Content
Scope
1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Urology Devices Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Urology Devices Market
2.1.1 Main Objective of the Global Urology Devices Market
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 TOP START-UPs UNDER UROLOGY DEVICES INDUSTRY
6 COVID-19 IMPACT
7 GLOBAL UROLOGY DEVICES MARKET REVENUE
8 MARKET INSIGHTS BY PRODUCT
8.1 Instruments
8.1.1 Dialysis Devices
8.1.2 Endoscopes and Endovision Systems
8.1.3 Lasers and Lithotripsy Devices
8.1.4 Other Instruments
8.2 Consumables and Accessories
8.2.1 Dialysis Consumables
8.2.2 Guidewires and Catheters
8.2.3 Stents
8.2.4 Biopsy Devices
8.2.5 Other Consumables and Accessories
9 MARKET INSIGHTS BY DISEASES
9.1 Kidney Diseases
9.2 Urological Cancer and BPH
9.3 Pelvic Organ Prolapse
9.4 Other Diseases
10 MARKET INSIGHTS BY END-USERS
10.1 Hospitals and Clinics
10.2 Dialysis Centers
10.3 Other End Users
11 MARKET INSIGHTS BY REGION
11.1 NORTH AMERICA UROLOGY DEVICES MARKET
11.1.1 United States
11.1.2 Canada
11.1.3 Rest of North America
11.2 EUROPE UROLOGY DEVICES MARKET
11.2.1 Germany
11.2.2 France
11.2.3 United Kingdom
11.2.4 Spain
11.2.5 Italy
11.2.6 Rest of Europe
11.3 ASIA PACIFIC UROLOGY DEVICES MARKET
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 Australia
11.3.5 Rest of Asia Pacific
11.4 REST OF THE WORLD UROLOGY DEVICES MARKET
12 UROLOGY DEVICES MARKET DYNAMICS
12.1 Market Drivers
12.2 Market Challenges
12.3 Impact Analysis
13 LEGAL & REGULATORY FRAMEWORK
14 DEMAND AND SUPPLY SIDE ANALYSIS
14.1 Demand Side Analysis
14.2 Supply Side Analysis
14.2.1 Top Product Launches
14.2.2 Top Business Partnerships
14.2.3 Top Merger & Acquisitions
15 VALUE CHAIN ANALYSIS
16 UROLOGY DEVICES MARKET OPPORTUNITIES
17 UROLOGY DEVICES MARKET TRENDS & INSIGHTS
18 COMPETITIVE SCENARIO
18.1 Porter's Five forces analysis
18.1.1 Bargaining power of Supplier
18.1.2 Bargaining power of Buyer
18.1.3 Industry Rivalry
18.1.4 Availability of Substitute
18.1.5 Threat of new Entrants
18.2 Competitive Landscape
19.2.1 Company Shares, By Revenue
19 COMPANY PROFILED
19.1 Medtronic plc
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Key Product/Services Offerings Revenue Split
19.1.4 Growth Strategy Financial Overview of Medtronic plc
19.1.5 SWOT Analysis
19.1.6 Key Financials Product Launch
19.1.6.1 Partnerships
19.1.6.2 Business Expansion and Investments
19.1.7 Recent Developments Merger and Acquisition
19.1.7.1 Product Launch
19.1.7.2 Partnerships
19.1.7.3 Business Expansion and Investments
19.1.7.4 Merger and Acquisition
19.2 Boston Scientific
19.3 C. R. Bard
19.4 Baxter
19.5 Siemens
19.6 Fresenius Medical Care AG & Co. KGaA
19.7 B. Braun Melsungen AG
19.8 Becton, Dickinson and Company
19.9 Stryker Corporation
19.10 Sanofi
20 DISCLAIMER
Licence Rights
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Companies
Baxter
Boston Scientific
C. R. Bard
Medtronic
Siemens
Fresenius Medical Care AG & Co. KGaA
B. Braun Melsungen AG
Becton
Dickinson and Company
Stryker Corporation
and Sanofi
Company Profile
Company Profile Title
Prevalence of various urological disorders has led to an upsurge in adoption of the urology devices globally. For instance, according to the American Urological Association Foundation (AUAF), benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections (UTIS), and kidney and ureteral stones are among the most common urological diseases. Moreover, as per the United States Department of Health and Human Services, the overall prevalence of CKD among the American population is about 14%, and almost half of the individuals with CKD suffer from diabetes and/or cardiovascular diseases. Annually, more than 661,000 Americans suffer from kidney failure, and 468,000 patients are given dialysis.
Urinary tract infections (UTIs) are one of the most common microbial diseases affecting people of all age groups. Globally, UTIs affect around 150 million people every year. Diabetic patients have a higher risk of developing UTIs and complications associated with it. With a global increase in diabetic population, complications, like dysuria and organ damage are associated with UTIs, that are also on the rise.
Based on product, the global Urology Devices market is segmented into instruments and consumables & accessories. Currently, instruments segment dominated the market and is expected to maintain its dominance during the forecast period owing to the technological advancements coupled with the launch of new and advanced urology instruments.
Based on diseases, the market is divided into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other diseases. Kidney diseases dominated the market in 2020 owing to the growing patient pool of chronic kidney disease due to the rising geriatric population.
Based on end-users, the market is segmented into hospitals and clinics, dialysis centers and others. Currently hospitals dominates the market and is expected to maintain its dominance during the analyzed period owing to the rising number of hospitals and infrastructural & economic development, especially in emerging countries.
For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for Urology Devices on account of increasing prevalence of chronic and lifestyle conditions, increasing healthcare spending, highly developed healthcare system in the US and Canada, and presence of a better reimbursement structure.
Some of the major players operating in the market includes Baxter, Boston Scientific, C. R. Bard, Medtronic, Siemens, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Becton, Dickinson and Company, Stryker Corporation, and Sanofi; etc.
Scope
1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Urology Devices Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Urology Devices Market
2.1.1 Main Objective of the Global Urology Devices Market
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 TOP START-UPs UNDER UROLOGY DEVICES INDUSTRY
6 COVID-19 IMPACT
7 GLOBAL UROLOGY DEVICES MARKET REVENUE
8 MARKET INSIGHTS BY PRODUCT
8.1 Instruments
8.1.1 Dialysis Devices
8.1.2 Endoscopes and Endovision Systems
8.1.3 Lasers and Lithotripsy Devices
8.1.4 Other Instruments
8.2 Consumables and Accessories
8.2.1 Dialysis Consumables
8.2.2 Guidewires and Catheters
8.2.3 Stents
8.2.4 Biopsy Devices
8.2.5 Other Consumables and Accessories
9 MARKET INSIGHTS BY DISEASES
9.1 Kidney Diseases
9.2 Urological Cancer and BPH
9.3 Pelvic Organ Prolapse
9.4 Other Diseases
10 MARKET INSIGHTS BY END-USERS
10.1 Hospitals and Clinics
10.2 Dialysis Centers
10.3 Other End Users
11 MARKET INSIGHTS BY REGION
11.1 NORTH AMERICA UROLOGY DEVICES MARKET
11.1.1 United States
11.1.2 Canada
11.1.3 Rest of North America
11.2 EUROPE UROLOGY DEVICES MARKET
11.2.1 Germany
11.2.2 France
11.2.3 United Kingdom
11.2.4 Spain
11.2.5 Italy
11.2.6 Rest of Europe
11.3 ASIA PACIFIC UROLOGY DEVICES MARKET
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 Australia
11.3.5 Rest of Asia Pacific
11.4 REST OF THE WORLD UROLOGY DEVICES MARKET
12 UROLOGY DEVICES MARKET DYNAMICS
12.1 Market Drivers
12.2 Market Challenges
12.3 Impact Analysis
13 LEGAL & REGULATORY FRAMEWORK
14 DEMAND AND SUPPLY SIDE ANALYSIS
14.1 Demand Side Analysis
14.2 Supply Side Analysis
14.2.1 Top Product Launches
14.2.2 Top Business Partnerships
14.2.3 Top Merger & Acquisitions
15 VALUE CHAIN ANALYSIS
16 UROLOGY DEVICES MARKET OPPORTUNITIES
17 UROLOGY DEVICES MARKET TRENDS & INSIGHTS
18 COMPETITIVE SCENARIO
18.1 Porter's Five forces analysis
18.1.1 Bargaining power of Supplier
18.1.2 Bargaining power of Buyer
18.1.3 Industry Rivalry
18.1.4 Availability of Substitute
18.1.5 Threat of new Entrants
18.2 Competitive Landscape
19.2.1 Company Shares, By Revenue
19 COMPANY PROFILED
19.1 Medtronic plc
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Key Product/Services Offerings Revenue Split
19.1.4 Growth Strategy Financial Overview of Medtronic plc
19.1.5 SWOT Analysis
19.1.6 Key Financials Product Launch
19.1.6.1 Partnerships
19.1.6.2 Business Expansion and Investments
19.1.7 Recent Developments Merger and Acquisition
19.1.7.1 Product Launch
19.1.7.2 Partnerships
19.1.7.3 Business Expansion and Investments
19.1.7.4 Merger and Acquisition
19.2 Boston Scientific
19.3 C. R. Bard
19.4 Baxter
19.5 Siemens
19.6 Fresenius Medical Care AG & Co. KGaA
19.7 B. Braun Melsungen AG
19.8 Becton, Dickinson and Company
19.9 Stryker Corporation
19.10 Sanofi
20 DISCLAIMER
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Companies
Baxter
Boston Scientific
C. R. Bard
Medtronic
Siemens
Fresenius Medical Care AG & Co. KGaA
B. Braun Melsungen AG
Becton
Dickinson and Company
Stryker Corporation
and Sanofi